1. Home
  2. ACHV vs DHY Comparison

ACHV vs DHY Comparison

Compare ACHV & DHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$5.27

Market Cap

172.0M

Sector

Health Care

ML Signal

HOLD

DHY

Credit Suisse High Yield Bond Fund

HOLD

Current Price

$1.74

Market Cap

240.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACHV
DHY
Founded
N/A
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
172.0M
240.4M
IPO Year
2018
1998

Fundamental Metrics

Financial Performance
Metric
ACHV
DHY
Price
$5.27
$1.74
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$14.67
N/A
AVG Volume (30 Days)
1.7M
584.5K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.00
$1.72
52 Week High
$6.16
$2.16

Technical Indicators

Market Signals
Indicator
ACHV
DHY
Relative Strength Index (RSI) 52.29 43.63
Support Level $4.09 N/A
Resistance Level $6.03 $2.05
Average True Range (ATR) 0.43 0.02
MACD -0.07 0.00
Stochastic Oscillator 33.21 30.43

Price Performance

Historical Comparison
ACHV
DHY

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

About DHY Credit Suisse High Yield Bond Fund

Credit Suisse High Yield Credit Fund is a diversified, closed-end management investment company. The Fund's principal investment objective is to generate current income. Capital appreciation is a secondary objective, pursued to the extent consistent with the Fund's primary income objective.

Share on Social Networks: